Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Acute Respiratory Distress Syndrome, SARS-CoV-2

In brief

Evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with acute respiratory distress syndrome (ARDS) associated with at least severe COVID-19

Key facts

Study ID
NCT04565249
Run by
Pliant Therapeutics, Inc.
People needed
6
Starts
2020-10-22
Expected to finish
2021-08-02
Last updated by the study team
2022-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.